DE69222295T2 - Pulverförmige pharmazeutische Zusammensetzung - Google Patents

Pulverförmige pharmazeutische Zusammensetzung

Info

Publication number
DE69222295T2
DE69222295T2 DE69222295T DE69222295T DE69222295T2 DE 69222295 T2 DE69222295 T2 DE 69222295T2 DE 69222295 T DE69222295 T DE 69222295T DE 69222295 T DE69222295 T DE 69222295T DE 69222295 T2 DE69222295 T2 DE 69222295T2
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
powdered pharmaceutical
carrier
chitin
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69222295T
Other languages
English (en)
Other versions
DE69222295D1 (de
Inventor
Patricia Elaine Koochaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of DE69222295D1 publication Critical patent/DE69222295D1/de
Publication of DE69222295T2 publication Critical patent/DE69222295T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
DE69222295T 1992-05-26 1992-05-26 Pulverförmige pharmazeutische Zusammensetzung Expired - Fee Related DE69222295T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92304712A EP0571671B1 (de) 1992-05-26 1992-05-26 Pulverförmige pharmazeutische Zusammensetzung

Publications (2)

Publication Number Publication Date
DE69222295D1 DE69222295D1 (de) 1997-10-23
DE69222295T2 true DE69222295T2 (de) 1998-04-09

Family

ID=8211374

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69222295T Expired - Fee Related DE69222295T2 (de) 1992-05-26 1992-05-26 Pulverförmige pharmazeutische Zusammensetzung

Country Status (7)

Country Link
EP (1) EP0571671B1 (de)
JP (1) JPH07507303A (de)
AT (1) ATE158172T1 (de)
AU (1) AU669902B2 (de)
CA (1) CA2136607C (de)
DE (1) DE69222295T2 (de)
WO (1) WO1993024149A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
TW431888B (en) * 1994-02-03 2001-05-01 Schering Plough Healthcare Nasal spray compositions
DE4404011A1 (de) * 1994-02-09 1995-08-10 Jenapharm Gmbh Neue, adhäsiv wirkende Zubereitungen für mit Flüssigkeit benetzte Oberflächen, Verfahren und Vorrichtung zur Erfassung der Adhäsionszeit diesbezüglicher Zubereitungen
KR100568436B1 (ko) * 1996-02-27 2007-04-25 데이진 가부시키가이샤 분말상경비투여조성물
ATE219657T1 (de) * 1998-01-30 2002-07-15 Novartis Consumer Health Sa Nasale lösungen
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS5823847B2 (ja) * 1981-02-06 1983-05-18 株式会社 林原生物化学研究所 抗ヒト蛋白質抗体の製造方法
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
JPS62236862A (ja) * 1986-04-09 1987-10-16 Nippon Kayaku Co Ltd 人工粘液
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici

Also Published As

Publication number Publication date
CA2136607A1 (en) 1993-12-09
EP0571671A1 (de) 1993-12-01
DE69222295D1 (de) 1997-10-23
CA2136607C (en) 2000-04-04
WO1993024149A1 (en) 1993-12-09
AU4223493A (en) 1993-12-30
EP0571671B1 (de) 1997-09-17
AU669902B2 (en) 1996-06-27
JPH07507303A (ja) 1995-08-10
ATE158172T1 (de) 1997-10-15

Similar Documents

Publication Publication Date Title
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
DE3688674D1 (de) Hydroxypropylcelluloseether enthaltende mittel mit verzoegerter wirkstoffabgabe.
ATE131039T1 (de) Arzneimittel in gelform in einem spender.
MY100721A (en) Therapeutic agent.
WO1995017156A3 (en) Ethanol substitutes
DE69022876D1 (de) Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
EP0995434A3 (de) Medizinische Aerosolformulierungen
ATE312080T1 (de) 2-chinolonen enthaltende arzneimittel
MY112915A (en) Multiple unit tableted dosage form 1
NZ501066A (en) Pharmaceutical formulations containing voriconazole and sulphobutylether beta-cyclodextrin
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
ATE469644T1 (de) Pharmazeutische zubereitung enthaltend n-ä2-(1,6, 7,8-tetrahydro-2h-indenoä5,4 büfuran-8- yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
DE69925293D1 (de) Sprühbeschichtete mikropartikel für nadellose spritzen
DE69222295T2 (de) Pulverförmige pharmazeutische Zusammensetzung
AU4519399A (en) Anti-inflammatory pharmaceutical formulations
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
AU2503900A (en) Sulfated phosphatidylinositols, their preparation and use
DE59205998D1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
FR2751967B1 (fr) Agents antipaludeens et antibabesioses et compositions pharmaceutiques les contenant
AU8079891A (en) Bile alcohol and drug containing the same as active ingredient
HUT75711A (en) The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone
IT8922398A0 (it) Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.
Boulinguez et al. Nicorandil-induced painful aphthae or ulcerations

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee